Verena Wally

Salzburg, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Long-term cytokine exposure remodels the methylome and transcriptome of recessive dystrophic epidermolysis bullosa keratinocytes - a bioinformatic analysis.

Long-term cytokine exposure remodels the methylome and transcriptome of recessive dystrophic epidermolysis bullosa keratinocytes - a bioinformatic analysis.

Journal: Frontiers in cell and developmental biology

Published: February 13, 2026

Tackling digit fusion: Immunomodulation as a game changer in RDEB.

Tackling digit fusion: Immunomodulation as a game changer in RDEB.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: September 30, 2025

Transcriptome-guided drug repurposing identifies selumetinib for an aggressive epithelial cancer.

Transcriptome-guided drug repurposing identifies selumetinib for an aggressive epithelial cancer.

Journal: The Journal of investigative dermatology

Published: June 25, 2025

Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosa.

Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosa.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: April 25, 2025

Serum MicroRNA signatures associated with hypertrophic callus formation in polytrauma patients with traumatic brain injury.

Serum MicroRNA signatures associated with hypertrophic callus formation in polytrauma patients with traumatic brain injury.

Journal: Scientific reports

Published: March 25, 2025

Keratin-associated epidermolysis bullosa simplex: phenotypes and challenges in clinical trials - a narrative review and systematic update.

Keratin-associated epidermolysis bullosa simplex: phenotypes and challenges in clinical trials - a narrative review and systematic update.

Journal: Orphanet journal of rare diseases

Published: January 28, 2025

Repurposing diacerein for the treatment of chronic wounds in recessive-dystrophic epidermolysis bullosa patients by modulating matrix metalloproteinase-9 expression.

Repurposing diacerein for the treatment of chronic wounds in recessive-dystrophic epidermolysis bullosa patients by modulating matrix metalloproteinase-9 expression.

Journal: The Journal of dermatology

Published: November 21, 2024

Core outcome domain sets for clinical trials in epidermolysis bullosa - a COSEB protocol to achieve consensus on "what" to measure.

Core outcome domain sets for clinical trials in epidermolysis bullosa - a COSEB protocol to achieve consensus on "what" to measure.

Journal: Trials

Published: October 15, 2024

HMCN1 variants aggravate epidermolysis bullosa simplex phenotype.

HMCN1 variants aggravate epidermolysis bullosa simplex phenotype.

Journal: The Journal of experimental medicine

Published: May 11, 2024

Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa.

Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa.

Journal: The British journal of dermatology

Published: April 02, 2024

Challenges and progress related to gene editing in rare skin diseases.

Challenges and progress related to gene editing in rare skin diseases.

Journal: Advanced drug delivery reviews

Published: December 15, 2023

Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa.

Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa.

Journal: International journal of molecular sciences

Published: December 01, 2023

Showing 1-12 of 54

Last Updated: 09/26/2026